… Association between lowering LDL-C and cardiovascularrisk reduction among different … Evolocumab and clinicaloutcomes in patients with card iovascular disease[J]. N Engl J Med,…
… Evolocumab and clinicaloutcomes in patients with cardio⁃ vascular disease[J].N Engl J … Control of cholesterol levels can reduces the incidence of atherosclerotic cardiovasculardisease…
… 依尤洛单抗 · Evolocumab and clinicaloutcomes in patients with cardiovasculardisease [11] 544 N Engl J Med · Effect of evolocumab on progression of coronary disease in statin-…
… Evolocumab and clinicaloutcomes in patients with cardiovasculardisease [J]. N Engl J Med… Efficacy and safety of evolocumab in reducing lipids and cardiovascularevents [J]. N Engl J …
… Evolocumab and clinicaloutcomes in patients with cardiovasculardisease[J].N Engl J Med,2017,376(18):1713-1722. [7] BHATT DL,… Evolocumab and clinicaloutcomes in patients with …
… The associations of muscle strength,muscle mass,and adiposity with clinicaloutcomes and quality … Evolocumab and clinicaloutcomes in patients with cardiovasculardisease[J]. JR Coll …
… Future research should focus on long-term effects and underlying mechanisms to provide comprehensive health management strategies for patients with cardiovasculardiseases. …
… risk factors for ischemic cardiovasculardiseases, PCSK9 inhibitors rapidly become a new hotspot of blood lipid management. Antibodies applied clinically are Alirocumab, Evolocumab …